【4282】EPSホールディングス〔上場廃止〕

ー(上場廃止)CRO(臨床試験受託)、CSO(医薬品販売支援)。

東証1部

サービス業サー

＞

CRO、SMO 治験

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2021.09	2021/08/03	Q3予	75,000	→	0.0%	+7.4%	5,500	→	0.0%	+14.6%	5,900	→	0.0%	+18.0%	3,300	→	0.0%	+26.9%
2021.09	2021/05/07	修正予	75,000	↑	+7.4%	+7.4%	5,500	↑	+14.6%	+14.6%	5,900	↑	+18.0%	+18.0%	3,300	↑	+26.9%	+26.9%
2021.09	2021/02/02	Q1予	69,800	→	0.0%	0.0%	4,800	→	0.0%	0.0%	5,000	→	0.0%	0.0%	2,600	→	0.0%	0.0%
2021.09	2020/11/05	当初予	69,800	-	-	-	4,800	-	-	-	5,000	-	-	-	2,600	-	-	-
2020.09	2020/11/05	実	66,689	↑	+5.0%	-8.0%	4,553	↑	+51.8%	-26.2%	4,978	↑	+65.9%	-21.2%	1,995	↑	+59.6%	-43.6%
2020.09	2020/08/04	修正予	63,500	→	0.0%	-12.4%	3,000	↑	+100.0%	-51.4%	3,000	↑	+76.5%	-52.5%	1,250	↑	+4.2%	-64.7%
2020.09	2020/05/08	修正予	63,500	↓	-12.4%	-12.4%	1,500	↓	-75.7%	-75.7%	1,700	↓	-73.1%	-73.1%	1,200	↓	-66.1%	-66.1%
2020.09	2020/02/04	Q1予	72,500	→	0.0%	0.0%	6,170	→	0.0%	0.0%	6,320	→	0.0%	0.0%	3,540	→	0.0%	0.0%
2020.09	2019/11/07	当初予	72,500	-	-	-	6,170	-	-	-	6,320	-	-	-	3,540	-	-	-
2019.09	2019/11/07	実	69,009	↑	+1.3%	-4.2%	6,279	↑	+10.2%	-12.8%	6,271	↑	+8.1%	-14.7%	3,633	↑	+21.1%	-22.7%
2019.09	2019/08/01	Q3予	68,100	↓	-5.4%	-5.4%	5,700	↓	-20.8%	-20.8%	5,800	↓	-21.1%	-21.1%	3,000	↓	-36.2%	-36.2%
2019.09	2019/05/08	Q2予	72,000	→	0.0%	0.0%	7,200	→	0.0%	0.0%	7,350	→	0.0%	0.0%	4,700	→	0.0%	0.0%
2019.09	2019/02/01	Q1予	72,000	→	0.0%	0.0%	7,200	→	0.0%	0.0%	7,350	→	0.0%	0.0%	4,700	→	0.0%	0.0%
2019.09	2018/11/07	当初予	72,000	-	-	-	7,200	-	-	-	7,350	-	-	-	4,700	-	-	-
2018.09	2018/11/07	実	65,769	↓	-0.3%	-0.3%	7,193	↑	+5.0%	+5.0%	7,436	↑	+6.2%	+6.2%	4,388	↑	+4.5%	+4.5%
2018.09	2018/08/01	Q3予	66,000	→	0.0%	0.0%	6,850	→	0.0%	0.0%	7,000	→	0.0%	0.0%	4,200	→	0.0%	0.0%
2018.09	2018/05/01	Q2予	66,000	→	0.0%	0.0%	-	-	-	-	7,000	→	0.0%	0.0%	4,200	→	0.0%	0.0%
2018.09	2018/02/01	Q1予	66,000	→	0.0%	0.0%	6,850	→	0.0%	0.0%	7,000	→	0.0%	0.0%	4,200	→	0.0%	0.0%
2018.09	2017/11/07	当初予	66,000	-	-	-	6,850	-	-	-	7,000	-	-	-	4,200	-	-	-
2017.09	2017/11/07	実	60,482	→	0.0%	+4.3%	7,591	→	0.0%	+16.8%	7,809	→	0.0%	+20.1%	4,663	→	0.0%	+33.2%
2017.09	2017/10/31	修正予	60,482	↑	+4.3%	+4.3%	7,591	↑	+16.8%	+16.8%	7,809	↑	+20.1%	+20.1%	4,663	↑	+33.2%	+33.2%
2017.09	2017/08/01	Q3予	58,000	→	0.0%	0.0%	6,500	→	0.0%	0.0%	6,500	→	0.0%	0.0%	3,500	→	0.0%	0.0%
2017.09	2017/05/02	Q2予	58,000	→	0.0%	0.0%	6,500	→	0.0%	0.0%	6,500	→	0.0%	0.0%	3,500	→	0.0%	0.0%
2017.09	2017/02/01	Q1予	58,000	→	0.0%	0.0%	6,500	→	0.0%	0.0%	6,500	→	0.0%	0.0%	3,500	→	0.0%	0.0%
2017.09	2016/11/08	当初予	58,000	-	-	-	6,500	-	-	-	6,500	-	-	-	3,500	-	-	-
2016.09	2016/11/08	実	52,703	↑	+0.4%	+10.3%	6,224	↑	+11.1%	+31.6%	6,589	↑	+9.8%	+41.7%	3,966	↑	+13.3%	+74.7%
2016.09	2016/08/01	修正予	52,500	→	0.0%	+9.8%	5,600	↑	+7.2%	+18.4%	6,000	↑	+9.1%	+29.0%	3,500	↑	+16.7%	+54.2%
2016.09	2016/05/02	Q2予	52,500	→	0.0%	+9.8%	-	-	-	-	5,500	→	0.0%	+18.3%	3,000	→	0.0%	+32.2%
2016.09	2016/04/26	修正予	52,500	↑	+1.5%	+9.8%	5,225	↑	+10.5%	+10.5%	5,500	↑	+18.3%	+18.3%	3,000	↑	+32.2%	+32.2%
2016.09	2016/02/01	修正予	51,700	↑	+8.2%	+8.2%	4,730	→	0.0%	0.0%	4,650	→	0.0%	0.0%	2,270	→	0.0%	0.0%
2016.09	2015/11/06	当初予	47,800	-	-	-	4,730	-	-	-	4,650	-	-	-	2,270	-	-	-
2015.09	2015/11/06	実	45,202	↑	+2.5%	+2.5%	5,482	↑	+18.5%	+18.5%	5,362	↑	+23.9%	+23.9%	2,163	↑	+11.7%	+11.7%
2015.09	2015/08/03	Q3予	44,120	→	0.0%	0.0%	4,625	→	0.0%	0.0%	4,327	→	0.0%	0.0%	1,937	→	0.0%	0.0%
2015.09	2015/05/01	Q2予	44,120	→	0.0%	0.0%	4,625	→	0.0%	0.0%	4,327	→	0.0%	0.0%	1,937	→	0.0%	0.0%
2015.09	2015/02/02	Q1予	44,120	→	0.0%	0.0%	4,625	→	0.0%	0.0%	4,327	→	0.0%	0.0%	1,937	→	0.0%	0.0%
2015.09	2014/11/06	当初予	44,120	-	-	-	4,625	-	-	-	4,327	-	-	-	1,937	-	-	-
2014.09	2014/11/06	実	41,800	-	-	-	4,491	-	-	-	4,242	-	-	-	1,828	-	-	-

【4282】EPSホールディングス 〔上場廃止〕 ー(上場廃止)CRO(臨床試験受託)、CSO(医薬品販売支援)。

業績予想修正履歴

【4282】EPSホールディングス〔上場廃止〕

ー(上場廃止)CRO(臨床試験受託)、CSO(医薬品販売支援)。